Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA) -enhanced hepatic MR imaging?

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 2, 2010, Pages 334-340

  Haradome, Hiroki ^a,b   Grazioli, Luigi ^a   Tsunoo, Mika ^a   Tinti, Rita ^a   Frittoli, Barbara ^a   Gambarini, Sebastiana ^a   Morone, Mario ^a   Motosugi, Utaroh ^c   Colagrande, Stefano ^d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Gadoxetic acid DTPA (Gd EOB DTPA); Injection rate; Liver; MR fluoroscopic triggering technique; MRI

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; AORTA; ARTICLE; ARTIFACT REDUCTION; CLINICAL PROTOCOL; FEMALE; FLUOROSCOPY; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER DISEASE; LIVER PARENCHYMA; MAGNETIC RESONANCE FLUOROSCOPY; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

ADULT; AGED; AGED, 80 AND OVER; ARTERIES; ARTIFACTS; CONTRAST MEDIA; FEMALE; FLUOROSCOPY; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 77955393158     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22241     Document Type: Article

References (17)

1. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopahtologic findings and spiral CT-initial observations. Radiology 2004;230:266-275.
2. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266-275.
3. Kim SH, Kim SH, Lee J, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Rentogenol 2009;192:1675-1681.
4. Motosugi U, Ichikawa T, Sou H, et al. Dilution method of gadolinium ethoxybenzyl diethylenetriaminapentaacetiv acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging 2009;30:849-854.
5. Wilman AH, Riederer SJ, King BF, Debbins JP, Rossman PJ, Ehman RL. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: application to the renal arteries. Radiology 1997;205:137-146.
6. Huston J III, Fain SB, Riederer SJ, Wilman AH, Bernstein MA, Busse RF. Carotid arteries: maximizing arterial to venous contrast in fluoroscopically triggered contrast-enhanced MR angiography with elliptic centric view ordering. Radiology 1999;211: 265-273.
7. Czervionke LF, Czervionke JM, Daniels DL, Haughton VM. Characteristic features of MR truncation artifacts. AJR Am J Rentogenol 1988;151:1219-1228.
8. Stadler A, Schima W, Ba-Ssalamah A, Kettenbach J, Eisenhuber E. Artifacts in body MR imaging: their appearance and how to eliminate them. Eur Radiol 2007;17:1242-1255. (Pubitemid 46691954)
9. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA 2000; 284:3043-3045.
10. Lee VS, Lavelle MT, Rofsky NM, et al. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 2000;215:365-372.
11. Lee JJ, Chang Y, Kang DS, et al. Optimizing of gadolinium-enhanced MR angiography by manipulation of acquisition and scan delay times. Eur Radiol 2001;11:754-766.
12. Awai K, Inoue M, Yagyu Y, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 2004; 233:682-688.
13. Han JK, Choi BI, Kim AY, Kim SJ. Contrast media in abdominal computed tomography: optimization of delivery methods. Korean J Radiol 2001;2:28-36.
14. Zech CJ, Vos B, Weinmann HJ, et al. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 2009;44: 305-310.
15. Ichikawa T, Erturk SM, Araki T. Multiphasic contrast-enhanced multidetector-row CT of the liver: contrast-enhancement theory and practical scan protocol with combination of fixed injection duration and patients' body-weight-tailed dose of contrast material. Eur J Radiol 2006;58:165-176.
16. Awai K, Hatcho A, Nakayama Y, et al. Simulation of aortic peak enhancement on MDCT using a contrast material flow phantom: feasibility study. AJR Am J Roentgenol 2006;186: 379-385. (Pubitemid 46100306)
17. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.